
Novel HCV NS3 degrader, reducing susceptibility to resistance mutations, potently inhibiting HCV in a клеточный infection model, exhibiting the most мощный degradation (DC50 of 50nM at 4h) of HCV NS3,
Novel HCV NS3 degrader, reducing susceptibility to resistance mutations, potently inhibiting HCV in a cellular infection model, exhibiting the most potent degradation (DC50 of 50nM at 4h) of HCV NS3,
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.